27 Mar

What pharma pros in China need to hit enforcement curveballs

China’s attempts to strengthen IP protection and harness innovation have accelerated in recent years. Adam Houldsworth explores how these reforms affect the unique challenges faced by those in the pharmaceutical industry, particularly for enforcement.

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth